GlassScriptPhysician profile
Charles L Morrison
NPI 1265636138
$279.27
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.23 · 2020: $51.63 · 2021: $109 · 2022: $74.50.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $68.04 | 2021-2022 | |
| Ethicon US, LLC | $64.74 | 2019-2022 | |
| Axonics, INC. | $50.86 | 2020-2021 | |
| Tela Bio, INC. | $35.64 | 2020-2021 | |
| Shire North American Group INC | $29.47 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.61 | 2022 | |
| Trevena, INC. | $11.91 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.